Message from the Director
Dear Fellowship Candidate:
The landscape of nephrology is changing. With more Americans living longer, nephrologists will be treating aging renal patients with multiple comorbid conditions, increasing functional dependence, cognitive impairment, and symptoms causing compromised quality of life, for years to come. The elderly with chronic kidney disease (CKD), especially those with end stage renal disease (ESRD) on dialysis, are a rapidly growing population.
CKD has become a geriatric disease and a predictor for cardiovascular events, hospitalizations — and all cause mortality. Current evidence supports a geriatric and palliative medicine perspective to optimally manage the frailty, complex pharmacology, challenging psychosocial issues, transitions of care and symptom burden that many of these patients will experience during their advanced chronic kidney disease and dialysis trajectory.
In recognition of this changing landscape and the rich history of nephrology, geriatrics, and palliative medicine at Icahn School of Medicine, we are delighted to offer a three-year integrated fellowship in nephrology (2 years) and either geriatric or palliative medicine (1 year). Fellows who complete the 3 year program will be board eligible in nephrology and either palliative medicine or geriatrics depending on which combined track is chosen. Our mission is to produce academic nephrologists who will become leaders in renal geriatric and palliative medicine whether they choose careers in clinical nephrology or biomedical research.
In addition to intensive nephrology training, the integrated fellowship also includes comprehensive education, experience, and exposure to the full spectrum of geriatric and palliative medicine issues and provides opportunities for research and clinician educator development.
This Mount Sinai fellowship provides a real opportunity for the motivated candidate. Fellows who complete our program are well prepared for a career in clinical practice, academic nephrology, and basic or clinical research. We are committed to our fellows and their success.